TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11932085

Group type: EXPERIMENTAL
Intervention: Intra-articular lidocaine (IAL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intravenous meperidine/diazepam (IVMD)
Number of subjects: 54
Study: 10910653

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Swaddled beside the mother
Number of subjects: 75

Group type: COMPARATOR
Intervention: Swaddled and separated from the mother
Number of subjects: 75
Study: 8553820

Group type: EXPERIMENTAL
Intervention: biodegradable self‐reinforced polyglycolide screws
Number of subjects: 29

Group type: COMPARATOR
Intervention: metallic implants
Number of subjects: 29
Study: 2653416

Group type: EXPERIMENTAL
Intervention: Provision of social support service by family workers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no social support service)
Number of subjects: 0
Study: 90354

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with adriamycin
Number of subjects: 117

Group type: COMPARATOR
Intervention: Combination chemotherapy without adriamycin
Number of subjects: 117
Study: 31682147

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standardized Episodic Thinking (SET)
Number of subjects: 43
Study: 31819291

Group type: EXPERIMENTAL
Intervention: Productivity losses due to P. vivax malaria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost of fluorescent spot test for P. vivax malaria
Number of subjects: 0
Study: 28056902

Group type: EXPERIMENTAL
Intervention: Direct observation of students' hat use during recess and lunch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Direct observation of teachers' use of sun protective measures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Measurement of sunscreen consumption by students
Number of subjects: 20
Study: 25041333

Group type: EXPERIMENTAL
Intervention: LTPP (one session/week)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Combination therapy (LTPP + fluoxetine)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Fluoxetine treatment (20‐60 mg/day)
Number of subjects: 272
Study: 23733915

Group type: EXPERIMENTAL
Intervention: High free fatty acid (FFA) levels (intralipid/heparin-infusion)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low free fatty acid (FFA) levels (hyperinsulinemic-euglycemic clamping)
Number of subjects: 18
Study: 21569237

Group type: EXPERIMENTAL
Intervention: Electronic record‐based intervention with electronic prompts to promote adherence with evidence‐based standards
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (family practices without the intervention)
Number of subjects: 0
Study: 19228620

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) plus stenting
Number of subjects: 951

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 951
Study: 16523837

Group type: EXPERIMENTAL
Intervention: Tecnis Z9000 IOL
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acrysof MA60BM IOL
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sensar Optiedge AR40e IOL
Number of subjects: 32
Study: 15083317

Group type: EXPERIMENTAL
Intervention: Soy cookies (52 mg isoflavones)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Soy-free cookies (no isoflavones)
Number of subjects: 14
Study: 12397006

Group type: EXPERIMENTAL
Intervention: Baseline measurements including coronary calcium measurement using computed tomography
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Measurement of ventricular mass and function using cardiac magnetic resonance imaging
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Measurement of flow-mediated brachial artery endothelial vasodilation
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Measurement of carotid intimal-medial wall thickness and distensibility of the carotid arteries using ultrasonography
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Measurement of peripheral vascular disease using ankle and brachial blood pressures
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Electrocardiography
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Assessments of microalbuminuria, standard CVD risk factors, sociodemographic factors, life habits, and psychosocial factors
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Blood samples for biochemical risk factors and genetic studies
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Follow-up through 2008 for identification and characterization of CVD events
Number of subjects: 6500
Study: 9806658

Group type: EXPERIMENTAL
Intervention: Low dose megestrol acetate (160 mg/day)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: High dose megestrol acetate (640 mg/day)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: PSA hazard score
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Average relative velocity of PSA
Number of subjects: 148
Study: 7714514

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral relapse prevention treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive clinical management
Number of subjects: 0
Study: 2622988

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 g/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sleep extension (10 hr TIB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 g/kg) after sleep extension
Number of subjects: 12
Study: 402406

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium nasal solution (4% aqueous solution)
Number of subjects: 104
Study: 31369675

Group type: EXPERIMENTAL
Intervention: Cervical headgear treatment (CH) started at age 7.8 years (Early Group - EG)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cervical headgear treatment (CH) started at age 9.5 years (Late Group - LG)
Number of subjects: 67
Study: 28894768

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid + 3% hypertonic solution
Number of subjects: 264

Group type: COMPARATOR
Intervention: 3% hypertonic solution
Number of subjects: 264
Study: 26112284

Group type: EXPERIMENTAL
Intervention: Interval cycling exercise training (set at 100% WRpeak with 30‐s work/30‐s rest intervals) for 12 weeks
Number of subjects: 25
Study: 23993873

Group type: EXPERIMENTAL
Intervention: Pupillographic Sleepiness Test (PST)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Subjective sleepiness assessment via questionnaires
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Objective sleepiness assessment via PST
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: PST reference values for lnPUI
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Comparison of subjective sleepiness and lnPUI
Number of subjects: 163
Study: 21199163

Group type: EXPERIMENTAL
Intervention: Early outpatient pulmonary rehabilitation programme (PRP) for 8 weeks, starting 2-3 weeks after discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 60
Study: 19689221

Group type: EXPERIMENTAL
Intervention: Eszopiclone
Number of subjects: 828
Study: 17942782

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate complex (1.5 mg/kg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate complex (3.0 mg/kg)
Number of subjects: 49
Study: 15337703

Group type: EXPERIMENTAL
Intervention: Pulmonary artery hypertension patients
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pulmonary artery hypertension patients treated with prostacyclin derivatives
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Peripheral chemoreflex deactivation with hyperoxia
Number of subjects: 17
Study: 11642232

Group type: EXPERIMENTAL
Intervention: 10(7) CFU of glycopeptide-resistant strains of Enterococcus faecium from chicken
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10(7) CFU of streptogramin-resistant strain of E. faecium from pig
Number of subjects: 18

Group type: COMPARATOR
Intervention: 10(7) CFU of glycopeptide-susceptible and streptogramin-susceptible strain of E. faecium from chicken
Number of subjects: 18
Study: 11263363

Group type: EXPERIMENTAL
Intervention: Bletilla striata angioembolus
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional gelfoam embolization
Number of subjects: 56
Study: 7930729

Group type: EXPERIMENTAL
Intervention: Bordetella pertussis infection in children 1-3 years
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Asymptomatic B. pertussis infection in preschool children
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Symptoms compatible with clinical pertussis in schoolchildren
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Attack rate of laboratory-confirmed B. pertussis infection
Number of subjects: 239
Study: 2850552

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 10
Study: 31291516

Group type: EXPERIMENTAL
Intervention: Rimegepant 75 mg
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1186
Study: 29969293

Group type: EXPERIMENTAL
Intervention: G‐CBT + ABM
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: G‐CBT + ACT
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: CT + ABM
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: CT + ACT
Number of subjects: 79
Study: 27275618

Group type: EXPERIMENTAL
Intervention: Osseointegrated implants subjected to 200-cN force
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (implants not subjected to orthodontic force)
Number of subjects: 0
Study: 24734969

Group type: EXPERIMENTAL
Intervention: Cognitive conflicts (presence of implicative dilemmas) in depressive patients
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Cognitive conflicts in depressive patients
Number of subjects: 271
Study: 23021168

Group type: EXPERIMENTAL
Intervention: Warm water (35°‐38°C)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Cool water (20°‐23°C)
Number of subjects: 175
Study: 20216276

Group type: EXPERIMENTAL
Intervention: Mediterranean diet, physical exercise, and daily oral ingestion of 40 mg of soy isoflavones
Number of subjects: 116

Group type: COMPARATOR
Intervention: Mediterranean diet and physical exercise (control group)
Number of subjects: 116
Study: 17711562

Group type: EXPERIMENTAL
Intervention: 3 g intravenous paracetamol
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 16311458

Group type: EXPERIMENTAL
Intervention: Logistic regression approach incorporating pre- and post-dilation lung function, age, sex, and height.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percentage of the predicted or baseline FEV1 increase.
Number of subjects: 0
Study: 12138364

Group type: EXPERIMENTAL
Intervention: Second-generation oral contraceptive (30 microg ethinylestradiol/150 microg levonorgestrel)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Third-generation oral contraceptive (30 microg ethinylestradiol/150 microg desogestrel)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Progestagen-only preparation (150 microg levonorgestrel)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Progestagen-only preparation (150 microg desogestrel)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-containing OC in women with factor V Leiden
Number of subjects: 86
Study: 9527763

Group type: COMPARATOR
Intervention: Indinavir at 1,000 mg every 8 h for 7 1/3 days with fluconazole placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fluconazole at 400 mg once daily for 8 days with indinavir placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Indinavir with fluconazole in combination
Number of subjects: 13
Study: 7599543

Group type: EXPERIMENTAL
Intervention: Methadone at 0.30 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine at 0.30 mg/kg
Number of subjects: 30
Study: 2090769

Group type: EXPERIMENTAL
Intervention: mezlocillin 2 g i.v. 15 to 20 minutes preoperatively
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: cefotetan 2 g i.v. 15 to 20 minutes preoperatively
Number of subjects: 184
Study: 359091

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate dry powder 150 microgram four times daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate dry powder 100 microgram four times daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional aerosol 100 microgram four times daily
Number of subjects: 20
Study: 30198199

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca compartment block (FICB)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral nerve block (FNB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 100
Study: 28088681

Group type: EXPERIMENTAL
Intervention: Cogmed working memory intervention
Number of subjects: 28
Study: 26892074

Group type: EXPERIMENTAL
Intervention: Recipe booklet and monthly reminder text messages
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard verbal dietary advice
Number of subjects: 75
Study: 25127545

Group type: EXPERIMENTAL
Intervention: Home-based assessment using a low-sensitivity pregnancy test and a pictorial instruction sheet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinic follow-up carried out by a doctor
Number of subjects: 0
Study: 22333662

Group type: EXPERIMENTAL
Intervention: Natamycin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 20661550

Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor agonist (pramipexole)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor antagonist (amisulpride)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 36
Study: 16971058

Group type: EXPERIMENTAL
Intervention: 10Hz rTMS over right DLPFC
Number of subjects: 6

Group type: COMPARATOR
Intervention: 10Hz rTMS over left DLPFC
Number of subjects: 6
Study: 15831781

Group type: EXPERIMENTAL
Intervention: Exenatide (10 µg) injected subcutaneously at 0 hours with acetaminophen (1000 mg) ingested at -1, 0, +1, +2, and +4 hours.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo injected subcutaneously at 0 hours with acetaminophen (1000 mg) ingested.
Number of subjects: 40
Study: 16492988

Group type: EXPERIMENTAL
Intervention: Prebiotic-supplemented milk formula (4.5 g/L)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control milk formula without prebiotics
Number of subjects: 140
Study: 11214767

Group type: EXPERIMENTAL
Intervention: 800 microg/day BDP via Easyhaler
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1600 microg/day BDP via Easyhaler
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1600 microg/day BDP via Diskhaler
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo via Easyhaler
Number of subjects: 15
Study: 8857499

Group type: EXPERIMENTAL
Intervention: Nighttime measurements in patients with Friedreich's ataxia
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nighttime measurements in healthy age-matched subjects
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Daytime measurements in patients with Friedreich's ataxia
Number of subjects: 19

Group type: COMPARATOR
Intervention: Daytime measurements in healthy age-matched subjects
Number of subjects: 19
Study: 1741999

Group type: COMPARATOR
Intervention: Simulated KFC at 0 degrees
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simulated KFC at 10 degrees
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simulated KFC at 20 degrees
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simulated KFC at 30 degrees
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simulated KFC at 40 degrees
Number of subjects: 10
Study: 6708116

Group type: EXPERIMENTAL
Intervention: Direct training of spousal communication skills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observation of videotaped simulations of direct training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bibliotherapy with telephone contacts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 30964972

Group type: EXPERIMENTAL
Intervention: Philips Sonicare TongueCare+ BreathRx regimen (STC)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Listerine Cool Mint antiseptic rinse (LCM)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Tongue brushing with an ADA reference manual toothbrush (MTB)
Number of subjects: 168
Study: 29777379

Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard of care (non-video group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (video and non-video)
Number of subjects: 62
Study: 26633738

Group type: EXPERIMENTAL
Intervention: Shirodkar cerclage
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: McDonald cerclage
Number of subjects: 98

Group type: COMPARATOR
Intervention: Bedrest (no cerclage)
Number of subjects: 98
Study: 24299553

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) containing 30 μg ethinyl estradiol and 3 mg drospirenone (group I; n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Contraceptive vaginal ring (group II; n = 19)
Number of subjects: 40
Study: 22764183

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 2128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2128
Study: 20154234

Group type: EXPERIMENTAL
Intervention: Anticipatory and Preventive Team Care (from family physicians, nurse practitioners, and a pharmacist)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study: 18771993

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 327
Study: 15975313

Group type: EXPERIMENTAL
Intervention: Conventional treatment with leeching intervention, n = 24
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional corticosteroid treated group (control group), n = 20
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between leeching group and control group
Number of subjects: 44
Study: 12669128

Group type: EXPERIMENTAL
Intervention: Coagulation reactivation observed at the time of recurrence with increased plasma TAT levels.
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Coagulation reactivation observed at the time of recurrence with increased plasma SF levels.
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: F1+2 levels measured preoperatively and at recurrence.
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Preoperative coagulation tests (F1+2, TAT, SF)
Number of subjects: 113
Study: 10228510

Group type: EXPERIMENTAL
Intervention: Electrolytically detachable coils (coil embolization)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Surgical ligation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 109

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 109
Study: 8767565

Group type: EXPERIMENTAL
Intervention: Hygroscopic HME (DAR Hygrobac S)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Heated humidifier (Fisher & Paykel MR 630 B)
Number of subjects: 49
Study: 1702557

Group type: EXPERIMENTAL
Intervention: Percutaneous drainage of pancreatic abscesses
Number of subjects: 85

Group type: COMPARATOR
Intervention: Surgical drainage of pancreatic abscesses
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Percutaneous drainage of infected pseudocysts
Number of subjects: 85

Group type: COMPARATOR
Intervention: Surgical drainage of infected pseudocysts
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Percutaneous aspiration of noninfected pseudocysts
Number of subjects: 85

Group type: COMPARATOR
Intervention: Surgical drainage of noninfected pseudocysts
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Percutaneous techniques
Number of subjects: 85
Study: 31310183

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) tool
Number of subjects: 941
Study: 29027235

Group type: EXPERIMENTAL
Intervention: Image-based denoising techniques or iterative reconstruction algorithms
Number of subjects: 103

Group type: COMPARATOR
Intervention: Commercially reconstructed quarter-dose images with no noise reduction
Number of subjects: 103

Group type: COMPARATOR
Intervention: Full-dose commercial images
Number of subjects: 103
Study: 25852024

Group type: EXPERIMENTAL
Intervention: GT3X
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Actiheart
Number of subjects: 10

Group type: COMPARATOR
Intervention: ActivPAL
Number of subjects: 10
Study: 23873853

Group type: EXPERIMENTAL
Intervention: Nalmefene 18 mg
Number of subjects: 667

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 667
Study: 21571362

Group type: EXPERIMENTAL
Intervention: Pirfenidone 2403 mg/day
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Pirfenidone 1197 mg/day
Number of subjects: 779

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 779
Study: 19265735

Group type: EXPERIMENTAL
Intervention: 15-minute HIV posttest educational video
Number of subjects: 128

Group type: COMPARATOR
Intervention: Posttest educational session with an HIV counselor
Number of subjects: 128
Study: 17546902

Group type: EXPERIMENTAL
Intervention: Chloroquine monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined therapy (Chloroquine + Sulfadoxine/pyrimethamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 15497491

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 20
Study: 11686428

Group type: EXPERIMENTAL
Intervention: 400 microg inhaled plus 200 microg intranasal budesonide once daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 10 mg montelukast plus 10 mg cetirizine once daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9307671

Group type: EXPERIMENTAL
Intervention: Calcium-channel antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0